Analyzing MiX Telematics (MIXT) & Epocrates (EPOC)

MiX Telematics (NYSE: MIXT) and Epocrates (NASDAQ:EPOC) are both small-cap technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, dividends, risk, analyst recommendations, earnings and valuation.

Earnings and Valuation

This table compares MiX Telematics and Epocrates’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
MiX Telematics $114.82 million 2.17 $8.65 million $0.39 28.49
Epocrates N/A N/A N/A ($0.30) -39.10

MiX Telematics has higher revenue and earnings than Epocrates. Epocrates is trading at a lower price-to-earnings ratio than MiX Telematics, indicating that it is currently the more affordable of the two stocks.

Dividends

MiX Telematics pays an annual dividend of $0.13 per share and has a dividend yield of 1.2%. Epocrates does not pay a dividend. MiX Telematics pays out 33.3% of its earnings in the form of a dividend.

Profitability

This table compares MiX Telematics and Epocrates’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
MiX Telematics 7.73% 8.99% 6.81%
Epocrates N/A N/A N/A

Insider and Institutional Ownership

27.1% of MiX Telematics shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and price targets for MiX Telematics and Epocrates, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MiX Telematics 0 2 1 0 2.33
Epocrates 0 0 0 0 N/A

MiX Telematics currently has a consensus price target of $15.00, indicating a potential upside of 35.01%. Given MiX Telematics’ higher possible upside, equities analysts clearly believe MiX Telematics is more favorable than Epocrates.

Summary

MiX Telematics beats Epocrates on 9 of the 10 factors compared between the two stocks.

About MiX Telematics

MiX Telematics Limited is a South Africa-based provider of fleet and mobile asset management solutions delivered as Software-as-a-Service (SaaS) to customers. The Company’s operating segments include Africa, Europe, Americas, Middle East and Australasia, Brazil and Central Services Organization. The Company’s products and services provide enterprise fleets, small fleets and consumers with solutions for safety, risk management and security. The Company’s solutions include MiX Fleet Manager, which consists of an on-board computer, an online tracking and information portal, as well as access to fleet and driver reports and analytics; MiX SafeDrive provides In-Vehicle Monitoring Systems (IVMS) that monitor driver performance, identify unsafe behaviors and provide audible alerts; Matrix is focused on personal safety and consumer telematics through vehicle tracking-and-recovery products and services, and Beam-e, which is a wireless device that fits into vehicles, motorbikes or caravan.

About Epocrates

Epocrates, Inc. (Epocrates) is a provider of mobile drug reference tools and electronic health records to healthcare professionals and interactive services to the healthcare industry. As of December 31, 2011, its user network consists of well over one million healthcare professionals, including approximately 340,000, or more than 50% of United States physicians. The Company offers its products on major United States mobile platforms, including Apple iOS, Android and BlackBerry. Epocrates operates in two segments: Subscriptions and Interactive Services, and Electronic Health Records. It uses brand names include DocAlert, Epocrates, Epocrates Honors, Epocrates ID, Epocrates Lab, Epocrates MedTools, Epocrates Rx, Epocrates Rx Pro, Epocrates Dx, Epocrates QuickSurvey, Epocrates QuickRecruit, Epocrates MedInsight, EssentialPoints and MedCafe. In October 2011, it launched a redesign of the drug reference tool to create a new platform that provides healthcare professionals.

What are top analysts saying about MiX Telematics Ltd -? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for MiX Telematics Ltd - and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit